{"id":348651,"date":"2025-08-25T14:49:44","date_gmt":"2025-08-25T14:49:44","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-goodrx-holdings\/"},"modified":"2025-08-25T14:49:44","modified_gmt":"2025-08-25T14:49:44","slug":"how-to-buy-goodrx-holdings","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-348651","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu GoodRx Holdings, Inc. (GDRX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu GoodRx Holdings, Inc. (GDRX)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu GoodRx Holdings, Inc. (GDRX) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu GoodRx Holdings, Inc. (GDRX)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings (GDRX) v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i $4.56, d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 quy tr\u00ecnh mua t\u1eebng b\u01b0\u1edbc cho c\u00e1c c\u01a1 h\u1ed9i c\u00f4ng ngh\u1ec7 ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings (GDRX) v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i $4.56, d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 quy tr\u00ecnh mua t\u1eebng b\u01b0\u1edbc cho c\u00e1c c\u01a1 h\u1ed9i c\u00f4ng ngh\u1ec7 ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c khai th\u00e1c th\u1ecb tr\u01b0\u1eddng thu\u1ed1c k\u00ea \u0111\u01a1n tr\u1ecb gi\u00e1 400 t\u1ef7 \u0111\u00f4 la? GoodRx Holdings (GDRX) \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ng\u01b0\u1eddi M\u1ef9 ti\u1ebft ki\u1ec7m chi ph\u00ed thu\u1ed1c men\u2014v\u00e0 danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n c\u00f3 th\u1ec3 h\u01b0\u1edfng l\u1ee3i. Nh\u00e0 \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe n\u00e0y k\u1ebft n\u1ed1i h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi v\u1edbi c\u00e1c \u0111\u01a1n thu\u1ed1c gi\u00e1 c\u1ea3 ph\u1ea3i ch\u0103ng \u0111\u1ed3ng th\u1eddi t\u1ea1o ra ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng \u0111\u1ea7u t\u01b0. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao GDRX x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch \u0111\u01b0a n\u00f3 v\u00e0o chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a b\u1ea1n.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c khai th\u00e1c th\u1ecb tr\u01b0\u1eddng thu\u1ed1c k\u00ea \u0111\u01a1n tr\u1ecb gi\u00e1 400 t\u1ef7 \u0111\u00f4 la? GoodRx Holdings (GDRX) \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a c\u00e1ch ng\u01b0\u1eddi M\u1ef9 ti\u1ebft ki\u1ec7m chi ph\u00ed thu\u1ed1c men\u2014v\u00e0 danh m\u1ee5c \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n c\u00f3 th\u1ec3 h\u01b0\u1edfng l\u1ee3i. Nh\u00e0 \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe n\u00e0y k\u1ebft n\u1ed1i h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi v\u1edbi c\u00e1c \u0111\u01a1n thu\u1ed1c gi\u00e1 c\u1ea3 ph\u1ea3i ch\u0103ng \u0111\u1ed3ng th\u1eddi t\u1ea1o ra ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng \u0111\u1ea7u t\u01b0. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao GDRX x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch \u0111\u01b0a n\u00f3 v\u00e0o chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a b\u1ea1n."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu GoodRx: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, GoodRx Holdings (GDRX) giao d\u1ecbch \u1edf m\u1ee9c <strong>$4.56<\/strong>\u2014m\u1ee9c gi\u00e1 khi\u1ebfn c\u00e1c nh\u00e0 ph\u00e2n t\u00edch b\u00e0n t\u00e1n v\u1ec1 ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1. Nh\u01b0ng h\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: <strong>Ng\u00e0y 6 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 c\u01a1 h\u1ed9i l\u1edbn ti\u1ebfp theo. \u0110\u00f3 l\u00e0 khi GoodRx c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3, v\u00e0 l\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y c\u00f3 th\u1ec3 t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3.<\/p> <h3>T\u1ea1i sao ng\u00e0y 6 th\u00e1ng 11 l\u1ea1i quan tr\u1ecdng nh\u1ea5t<\/h3> <p>Nh\u00ecn l\u1ea1i ph\u1ea3n \u1ee9ng v\u1edbi c\u00e1c b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn g\u1ea7n \u0111\u00e2y cho th\u1ea5y m\u1ed9t m\u00f4 h\u00ecnh r\u00f5 r\u00e0ng. B\u00e1o c\u00e1o qu\u00fd 2 ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025 \u0111\u00e3 t\u1ea1o ra s\u1ef1 bi\u1ebfn \u0111\u1ed9ng l\u1edbn, v\u1edbi c\u1ed5 phi\u1ebfu giao d\u1ecbch trong kho\u1ea3ng t\u1eeb $3.40 \u0111\u1ebfn $3.55 quanh th\u1eddi \u0111i\u1ec3m c\u00f4ng b\u1ed1. Bi\u1ebfn \u0111\u1ed9ng trong ng\u00e0y 4,4% l\u00e0 \u0111i\u1ec3n h\u00ecnh \u0111\u1ed1i v\u1edbi GDRX, v\u1ed1n c\u00f3 bi\u1ebfn \u0111\u1ed9ng h\u00e0ng tu\u1ea7n 13,9% so v\u1edbi m\u1ee9c trung b\u00ecnh 8,6% c\u1ee7a ng\u00e0nh ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe.<\/p> <p>B\u00e1o c\u00e1o qu\u00fd 1 tr\u01b0\u1edbc \u0111\u00f3 v\u00e0o th\u00e1ng 5 n\u0103m 2025 cho th\u1ea5y s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u00f2n \u1ea5n t\u01b0\u1ee3ng h\u01a1n\u2014c\u1ed5 phi\u1ebfu t\u0103ng t\u1eeb $3.73 v\u00e0o ng\u00e0y 15 th\u00e1ng 8 l\u00ean $5.06 v\u00e0o ng\u00e0y 18 th\u00e1ng 8, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng m\u1ee9c t\u0103ng 35,66% ch\u1ec9 trong ba ng\u00e0y sau tin t\u1ee9c h\u1ee3p t\u00e1c t\u00edch c\u1ef1c v\u1edbi Novo Nordisk.<\/p> <h3>Ph\u00e2n t\u00edch m\u00f4 h\u00ecnh ph\u1ea3n \u1ee9ng l\u1ee3i nhu\u1eadn<\/h3> <ul> <li><strong>Qu\u00fd 2 n\u0103m 2025 (7 th\u00e1ng 8)<\/strong>: Bi\u1ebfn \u0111\u1ed9ng trong ng\u00e0y 4,4% quanh b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/li> <li><strong>Qu\u00fd 1 n\u0103m 2025 (th\u00e1ng 5)<\/strong>: T\u0103ng 35,66% sau tin t\u1ee9c h\u1ee3p t\u00e1c<\/li> <li><strong>Qu\u00fd 4 n\u0103m 2024<\/strong>: Bi\u1ebfn \u0111\u1ed9ng \u0111i\u1ec3n h\u00ecnh 8-12% trong tu\u1ea7n b\u00e1o c\u00e1o<\/li> <li><strong>Qu\u00fd 3 n\u0103m 2024<\/strong>: Bi\u1ebfn \u0111\u1ed9ng 15% do k\u1ebft qu\u1ea3 h\u1ed7n h\u1ee3p<\/li> <li><strong>Qu\u00fd 2 n\u0103m 2024<\/strong>: Gi\u1ea3m 9% do lo ng\u1ea1i v\u1ec1 h\u01b0\u1edbng d\u1eabn<\/li> <li><strong>Qu\u00fd 1 n\u0103m 2024<\/strong>: T\u0103ng 22% nh\u1edd v\u01b0\u1ee3t k\u1ef3 v\u1ecdng t\u0103ng tr\u01b0\u1edfng \u0111\u0103ng k\u00fd<\/li> <\/ul> <p>M\u00f4 h\u00ecnh? GoodRx ph\u1ea3n \u1ee9ng m\u1ea1nh m\u1ebd v\u1edbi c\u1ea3 b\u1ea5t ng\u1edd l\u1ee3i nhu\u1eadn v\u00e0 th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c. C\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 th\u00f4ng minh theo d\u00f5i c\u00e1c ch\u1ea5t x\u00fac t\u00e1c n\u00e0y.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u00e0u L\u01b0\u1ee3n C\u1ea3m X\u00fac C\u00f3 M\u1ee5c \u0110\u00edch<\/h2> <p>Hi\u1ec7u su\u1ea5t g\u1ea7n \u0111\u00e2y c\u1ee7a GoodRx gi\u1ed1ng nh\u01b0 m\u1ed9t cu\u1ed1n ti\u1ec3u thuy\u1ebft ly k\u1ef3\u2014\u0111\u1ea7y nh\u1eefng kh\u00fac quanh nh\u01b0ng c\u00f3 c\u1ed1t truy\u1ec7n h\u1ea5p d\u1eabn. T\u1eeb th\u00e1ng 3 \u0111\u1ebfn th\u00e1ng 8 n\u0103m 2025, GDRX \u0111\u00e3 mang l\u1ea1i <strong>t\u0103ng 19,06%<\/strong> b\u1ea5t ch\u1ea5p nh\u1eefng th\u00e1ch th\u1ee9c c\u1ee7a ng\u00e0nh ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe.<\/p> <h3>Ph\u00e2n t\u00edch theo th\u00e1ng:<\/h3> <ul> <li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: $3.85 (b\u00e1n th\u00e1o ng\u00e0nh ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe tr\u00ean di\u1ec7n r\u1ed9ng)<\/li> <li><strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: $4.20 (+9% ph\u1ee5c h\u1ed3i)<\/li> <li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: $4.65 (+11% nh\u1edd v\u01b0\u1ee3t k\u1ef3 v\u1ecdng l\u1ee3i nhu\u1eadn qu\u00fd 1)<\/li> <li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: $4.10 (-12% lu\u00e2n chuy\u1ec3n ng\u00e0nh)<\/li> <li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: $4.75 (+16% \u0111\u1ed3n \u0111o\u00e1n h\u1ee3p t\u00e1c)<\/li> <li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: $4.56 (-4% h\u1ee3p nh\u1ea5t sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn)<\/li> <\/ul> <p>\u0110i\u1ec1u g\u00ec \u0111\u00e3 th\u00fac \u0111\u1ea9y bi\u1ebfn \u0111\u1ed9ng n\u00e0y? Ba y\u1ebfu t\u1ed1 ch\u00ednh: s\u1ef1 kh\u00f4ng ch\u1eafc ch\u1eafn c\u1ee7a th\u1ecb tr\u01b0\u1eddng thu\u1ed1c k\u00ea \u0111\u01a1n, tin t\u1ee9c m\u1edf r\u1ed9ng d\u1ecbch v\u1ee5 y t\u1ebf t\u1eeb xa, v\u00e0 h\u1ee3p t\u00e1c l\u1edbn v\u1edbi Novo Nordisk \u0111\u00e3 \u0111\u1ea9y c\u1ed5 phi\u1ebfu t\u0103ng 35% trong v\u00e0i ng\u00e0y.<\/p> <p>Ph\u1ea1m vi gi\u00e1 trong 52 tu\u1ea7n c\u1ee7a c\u1ed5 phi\u1ebfu k\u1ec3 c\u00e2u chuy\u1ec7n l\u1edbn h\u01a1n\u2014t\u1eeb m\u1ee9c th\u1ea5p $3.31 \u0111\u1ebfn cao $8.80. \u0110\u00f3 l\u00e0 <strong>ti\u1ec1m n\u0103ng t\u0103ng 166%<\/strong> t\u1eeb m\u1ee9c hi\u1ec7n t\u1ea1i n\u1ebfu GDRX c\u00f3 th\u1ec3 l\u1ea5y l\u1ea1i \u0111\u1ec9nh. Ngay c\u1ea3 m\u1ee9c gi\u00e1 trung b\u00ecnh 52 tu\u1ea7n $5.24 c\u0169ng cho th\u1ea5y ti\u1ec1m n\u0103ng t\u0103ng 15% t\u1eeb \u0111\u00e2y.<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Qu\u1ef9 \u0110\u1ea1o T\u0103ng Tr\u01b0\u1edfng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 n\u1ec1n t\u1ea3ng c\u00f4ng ty, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 mang l\u1ea1i:<\/p> <ul> <li><strong>M\u1ee5c ti\u00eau cu\u1ed1i n\u0103m 2025<\/strong>: $7.86 (<strong>+72% so v\u1edbi hi\u1ec7n t\u1ea1i<\/strong>)<br>C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 \u0111o\u00e1n th\u00e1ng 12 c\u00f3 th\u1ec3 th\u1ea5y GDRX \u0111\u1ea1t $12.05 n\u1ebfu \u0111\u00e0 h\u1ee3p t\u00e1c ti\u1ebfp t\u1ee5c, m\u1eb7c d\u00f9 m\u1ee9c trung b\u00ecnh th\u1eadn tr\u1ecdng h\u01a1n l\u00e0 $7.86 c\u00f3 v\u1ebb th\u1ef1c t\u1ebf do c\u00e1c r\u00e0o c\u1ea3n ph\u00e1p l\u00fd.<\/li> <li><strong>Tri\u1ec3n v\u1ecdng 2026<\/strong>: $17.21 (<strong>+277% so v\u1edbi hi\u1ec7n t\u1ea1i<\/strong>)<br>M\u1ee5c ti\u00eau tham v\u1ecdng n\u00e0y gi\u1ea3 \u0111\u1ecbnh m\u1edf r\u1ed9ng d\u1ecbch v\u1ee5 y t\u1ebf t\u1eeb xa th\u00e0nh c\u00f4ng v\u00e0 gi\u00e0nh th\u1ecb ph\u1ea7n t\u1eeb c\u00e1c nh\u00e0 qu\u1ea3n l\u00fd l\u1ee3i \u00edch d\u01b0\u1ee3c ph\u1ea9m truy\u1ec1n th\u1ed1ng.<\/li> <li><strong>D\u1ef1 b\u00e1o 2028<\/strong>: Ph\u1ea1m vi $25-30<br>\u0110\u1ebfn n\u0103m 2028, d\u1ef1 ki\u1ebfn GoodRx s\u1ebd th\u1ed1ng l\u0129nh kh\u00f4ng gian \u0111\u01a1n thu\u1ed1c k\u1ef9 thu\u1eadt s\u1ed1 v\u1edbi ti\u1ec1m n\u0103ng m\u1edf r\u1ed9ng qu\u1ed1c t\u1ebf.<\/li> <li><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: Ti\u1ec1m n\u0103ng $40-50<br>N\u1ebfu s\u1ed1 h\u00f3a ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe t\u0103ng t\u1ed1c nh\u01b0 d\u1ef1 ki\u1ebfn, GDRX c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t c\u1ed5 phi\u1ebfu h\u1ea1 t\u1ea7ng y t\u1ebf t\u1eeb xa kh\u00f4ng th\u1ec3 thi\u1ebfu.<\/li> <\/ul> <p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n. T\u1ef7 l\u1ec7 r\u1ee7i ro-l\u1ee3i nhu\u1eadn \u1edf m\u1ee9c hi\u1ec7n t\u1ea1i \u1ee7ng h\u1ed9 t\u00edch l\u0169y, m\u1eb7c d\u00f9 trung b\u00ecnh gi\u00e1 theo t\u1eebng \u0111\u1ee3t qua b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn th\u00e1ng 11 l\u00e0 kh\u00f4n ngoan.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh so v\u1edbi T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i ro khi\u1ebfn nh\u00e0 giao d\u1ecbch tr\u0103n tr\u1edf:<\/h3> <ul> <li><strong>R\u1ee7i ro ph\u00e1p l\u00fd<\/strong>: Lu\u1eadt ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe thay \u0111\u1ed5i li\u00ean t\u1ee5c\u2014m\u1ed9t d\u1ef1 lu\u1eadt x\u1ea5u c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng m\u00f4 h\u00ecnh kinh doanh<\/li> <li><strong>B\u1ea5t \u1ed5n ng\u00e0nh d\u01b0\u1ee3c<\/strong>: V\u1ee5 ph\u00e1 s\u1ea3n c\u1ee7a Rite Aid cho th\u1ea5y s\u1ef1 mong manh c\u1ee7a ng\u00e0nh (<a href=\"https:\/\/www.ainvest.com\/news\/gdrx-high-risk-hold-sell-signal-2025-clash-momentum-fundamentals-2508\/\">AInvest<\/a>)<\/li> <li><strong>Bi\u1ebfn \u0111\u1ed9ng cao<\/strong>: Bi\u1ebfn \u0111\u1ed9ng h\u00e0ng tu\u1ea7n 14% g\u00e2y c\u1ea3m gi\u00e1c c\u0103ng th\u1eb3ng<\/li> <li><strong>Nh\u1ea1y c\u1ea3m kinh t\u1ebf<\/strong>: Suy tho\u00e1i l\u00e0m gi\u1ea3m chi ti\u00eau thu\u1ed1c k\u00ea \u0111\u01a1n ngay l\u1eadp t\u1ee9c<\/li> <\/ul> <h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025:<\/h3> <ul> <li><strong>Y\u00eau th\u00edch c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: 9 nh\u00e0 ph\u00e2n t\u00edch \u0111\u1eb7t m\u1ee5c ti\u00eau trung b\u00ecnh $6.33 (<strong>+39% ti\u1ec1m n\u0103ng t\u0103ng<\/strong>)<\/li> <li><strong>S\u1ee9c m\u1ea1nh h\u1ee3p t\u00e1c<\/strong>: Th\u1ecfa thu\u1eadn v\u1edbi Novo Nordisk cho th\u1ea5y s\u1ef1 c\u00f4ng nh\u1eadn t\u1eeb ng\u00e0nh d\u01b0\u1ee3c l\u1edbn<\/li> <li><strong>T\u0103ng tr\u01b0\u1edfng y t\u1ebf t\u1eeb xa<\/strong>: GoodRx Care m\u1edf r\u1ed9ng nhanh ch\u00f3ng<\/li> <li><strong>Xu h\u01b0\u1edbng ng\u00e0nh<\/strong>: \u00c1p d\u1ee5ng y t\u1ebf k\u1ef9 thu\u1eadt s\u1ed1 t\u0103ng t\u1ed1c sau \u0111\u1ea1i d\u1ecbch<\/li> <li><strong>S\u1ee9c kh\u1ecfe t\u00e0i ch\u00ednh<\/strong>: Doanh thu qu\u00fd 2 \u0111\u1ea1t $203 tri\u1ec7u v\u1edbi bi\u00ean l\u1ee3i nhu\u1eadn g\u1ed9p 93,68%<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Mua 10-20 c\u1ed5 phi\u1ebfu \u0111\u1ec3 th\u1eed nghi\u1ec7m\u2014bi\u1ebfn \u0111\u1ed9ng c\u1ee7a GDRX \u0111\u00f2i h\u1ecfi s\u1ef1 th\u1eadn tr\u1ecdng<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o l\u1ee3i nhu\u1eadn<\/strong>: \u0110\u00e1nh d\u1ea5u ng\u00e0y 6 th\u00e1ng 11 v\u00e0 l\u00ean k\u1ebf ho\u1ea1ch v\u00e0o l\u1ec7nh quanh k\u1ebft qu\u1ea3<\/li> <li><strong>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n<\/strong>: Kh\u00f4ng bao gi\u1edd d\u00f9ng l\u1ec7nh th\u1ecb tr\u01b0\u1eddng cho c\u1ed5 phi\u1ebfu n\u00e0y\u2014bi\u00ean \u0111\u1ed9 gi\u00e1 c\u00f3 th\u1ec3 r\u1ed9ng<\/li> <li><strong>\u0110a d\u1ea1ng h\u00f3a th\u00f4ng minh<\/strong>: Gi\u1eef GDRX d\u01b0\u1edbi 5% t\u1ed5ng danh m\u1ee5c \u0111\u1ea7u t\u01b0<\/li> <li><strong>Theo d\u00f5i tin t\u1ee9c ng\u00e0nh d\u01b0\u1ee3c<\/strong>: Th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c \u1ea3nh h\u01b0\u1edfng c\u1ed5 phi\u1ebfu nhi\u1ec1u h\u01a1n b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/li> <\/ol> <p>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc c\u1ee7a ng\u01b0\u1eddi c\u00f3 kinh nghi\u1ec7m: \"Giao d\u1ecbch GDRX gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i n\u0103ng nh\u01b0ng kh\u00f3 \u0111o\u00e1n\u2014ti\u1ec1m n\u0103ng h\u1ed3i h\u1ed9p nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb thu\u1ed1c ki\u00ean nh\u1eabn!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu GoodRx Holdings, Inc. (GDRX) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn N\u1ec1n T\u1ea3ng<\/td><td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 truy c\u1eadp NASDAQ v\u00e0 cho ph\u00e9p mua c\u1ed5 phi\u1ebfu l\u1ebb<\/td><\/tr> <tr><td>2<\/td><td>N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi $100-500 \u0111\u1ec3 l\u00e0m quen v\u1edbi nh\u1ecbp \u0111i\u1ec7u c\u1ed5 phi\u1ebfu<\/td><\/tr> <tr><td>3<\/td><td>Nghi\u00ean C\u1ee9u Gi\u00e1 Hi\u1ec7n T\u1ea1i<\/td><td>Ki\u1ec3m tra bi\u1ebfn \u0111\u1ed9ng tr\u01b0\u1edbc gi\u1edd m\u1edf c\u1eeda v\u00e0 sau gi\u1edd giao d\u1ecbch<\/td><\/tr> <tr><td>4<\/td><td>\u0110\u1eb7t L\u1ec7nh Gi\u1edbi H\u1ea1n<\/td><td>\u0110\u1eb7t \u1edf m\u1ee9c $4.50 ho\u1eb7c th\u1ea5p h\u01a1n \u0111\u1ec3 tr\u00e1nh tr\u1ea3 gi\u00e1 cao<\/td><\/tr> <tr><td>5<\/td><td>X\u00e1c Nh\u1eadn K\u00edch Th\u01b0\u1edbc V\u1ecb Th\u1ebf<\/td><td>Gi\u1eef kho\u1ea3n \u0111\u1ea7u t\u01b0 ban \u0111\u1ea7u d\u01b0\u1edbi 3% t\u1ed5ng danh m\u1ee5c<\/td><\/tr> <tr><td>6<\/td><td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td><td>$3.80 l\u00e0 h\u1ed7 tr\u1ee3 v\u00e0 $5.20 l\u00e0 kh\u00e1ng c\u1ef1 quan tr\u1ecdng<\/td><\/tr> <tr><td>7<\/td><td>\u0110\u00e1nh Gi\u00e1 H\u00e0ng Qu\u00fd<\/td><td>Theo d\u00f5i c\u00e1c ch\u1ec9 s\u1ed1 kh\u1ed1i l\u01b0\u1ee3ng \u0111\u01a1n thu\u1ed1c trong b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/td><\/tr> <tr><td>8<\/td><td>Theo D\u00f5i Tin T\u1ee9c Ng\u00e0nh<\/td><td>Thay \u0111\u1ed5i ch\u00ednh s\u00e1ch ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe \u1ea3nh h\u01b0\u1edfng l\u1edbn \u0111\u1ebfn GDRX<\/td><\/tr> <tr><td>9<\/td><td>Xem X\u00e9t DRIP<\/td><td>T\u1ef1 \u0111\u1ed9ng t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c n\u1ebfu c\u00f3<\/td><\/tr> <tr><td>10<\/td><td>\u0110\u00e1nh Gi\u00e1 L\u1ea1i Chi\u1ebfn L\u01b0\u1ee3c H\u00e0ng Qu\u00fd<\/td><td>\u0110i\u1ec1u ch\u1ec9nh d\u1ef1a tr\u00ean c\u00e1c th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 GoodRx<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi theo d\u00f5i bi\u1ebfn \u0111\u1ed9ng c\u1ee7a GDRX, Pocket Option mang l\u1ea1i nh\u1eefng l\u1ee3i th\u1ebf \u0111\u1ed9c \u0111\u00e1o:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u $5<\/strong>\u2014ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi k\u00edch th\u01b0\u1edbc v\u1ecb th\u1ebf nh\u1ecf ph\u00f9 h\u1ee3p v\u1edbi h\u1ed3 s\u01a1 r\u1ee7i ro c\u1ee7a GDRX<\/li> <li><strong>X\u00e1c minh KYC trong 1 ph\u00fat<\/strong>\u2014t\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong c\u00e1c giai \u0111o\u1ea1n b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn quan tr\u1ecdng<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong>\u2014truy c\u1eadp l\u1ee3i nhu\u1eadn ngay khi GDRX c\u00f3 nh\u1eefng bi\u1ebfn \u0111\u1ed9ng nhanh \u0111\u1eb7c tr\u01b0ng<\/li> <\/ul> <p>T\u1ed1c \u0111\u1ed9 th\u1ef1c thi nhanh c\u1ee7a n\u1ec1n t\u1ea3ng l\u00fd t\u01b0\u1edfng \u0111\u1ec3 n\u1eafm b\u1eaft c\u00e1c bi\u1ebfn \u0111\u1ed9ng 14% h\u00e0ng tu\u1ea7n c\u1ee7a GoodRx, trong khi m\u1ee9c n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p gi\u00fap b\u1ea1n luy\u1ec7n t\u1eadp qu\u1ea3n l\u00fd v\u1ecb th\u1ebf m\u00e0 kh\u00f4ng b\u1ecb ph\u01a1i b\u00e0y qu\u00e1 m\u1ee9c.<\/p> <h2>\ud83c\udf0d GoodRx N\u0103m 2025: C\u1ea7u N\u1ed1i K\u1ef9 Thu\u1eadt S\u1ed1 Trong Ch\u0103m S\u00f3c S\u1ee9c Kh\u1ecfe<\/h2> <p>GoodRx Holdings kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu\u2014\u0111\u00f3 l\u00e0 m\u1ed9t cu\u1ed9c c\u00e1ch m\u1ea1ng trong ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe. C\u00f4ng ty k\u1ebft n\u1ed1i h\u01a1n 20 tri\u1ec7u ng\u01b0\u1eddi M\u1ef9 v\u1edbi thu\u1ed1c men gi\u00e1 c\u1ea3 ph\u1ea3i ch\u0103ng th\u00f4ng qua n\u1ec1n t\u1ea3ng so s\u00e1nh gi\u00e1, gi\u00fap ng\u01b0\u1eddi d\u00f9ng ti\u1ebft ki\u1ec7m kho\u1ea3ng 30 t\u1ef7 \u0111\u00f4 la k\u1ec3 t\u1eeb khi th\u00e0nh l\u1eadp.<\/p> <p>V\u1edbi 25% th\u1ecb ph\u1ea7n trong ti\u1ebft ki\u1ec7m thu\u1ed1c k\u00ea \u0111\u01a1n, GoodRx chi\u1ebfm \u01b0u th\u1ebf so v\u1edbi c\u00e1c \u0111\u1ed1i th\u1ee7 nh\u01b0 SingleCare (15%) v\u00e0 WellRx (10%). Vi\u1ec7c m\u1edf r\u1ed9ng sang d\u1ecbch v\u1ee5 y t\u1ebf t\u1eeb xa qua GoodRx Care gi\u00fap h\u1ecd c\u00f3 v\u1ecb th\u1ebf ho\u00e0n h\u1ea3o cho t\u01b0\u01a1ng lai k\u1ef9 thu\u1eadt s\u1ed1 c\u1ee7a ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe.<\/p> <p><strong>S\u1ef1 ki\u1ec7n th\u00fa v\u1ecb n\u0103m 2025<\/strong>: D\u1eef li\u1ec7u c\u1ee7a GoodRx cho th\u1ea5y trong \u0111\u1ee3t n\u1eafng n\u00f3ng th\u00e1ng 8 n\u0103m 2025, l\u01b0\u1ee3t t\u00ecm ki\u1ebfm thu\u1ed1c hen suy\u1ec5n t\u0103ng 300% \u1edf c\u00e1c bang Trung T\u00e2y\u2014n\u1ec1n t\u1ea3ng \u0111\u1ecbnh gi\u00e1 theo th\u1eddi gian th\u1ef1c c\u1ee7a h\u1ecd \u0111\u00e3 gi\u00fap b\u1ec7nh nh\u00e2n t\u00ecm \u0111\u01b0\u1ee3c \u1ed1ng h\u00edt kh\u1ea9n c\u1ea5p v\u1edbi m\u1ee9c gi\u1ea3m gi\u00e1 l\u00ean \u0111\u1ebfn 80% trong kh\u1ee7ng ho\u1ea3ng.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu GoodRx: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, GoodRx Holdings (GDRX) giao d\u1ecbch \u1edf m\u1ee9c <strong>$4.56<\/strong>\u2014m\u1ee9c gi\u00e1 khi\u1ebfn c\u00e1c nh\u00e0 ph\u00e2n t\u00edch b\u00e0n t\u00e1n v\u1ec1 ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1. Nh\u01b0ng h\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: <strong>Ng\u00e0y 6 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 c\u01a1 h\u1ed9i l\u1edbn ti\u1ebfp theo. \u0110\u00f3 l\u00e0 khi GoodRx c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3, v\u00e0 l\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y c\u00f3 th\u1ec3 t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3.<\/p>\n<h3>T\u1ea1i sao ng\u00e0y 6 th\u00e1ng 11 l\u1ea1i quan tr\u1ecdng nh\u1ea5t<\/h3>\n<p>Nh\u00ecn l\u1ea1i ph\u1ea3n \u1ee9ng v\u1edbi c\u00e1c b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn g\u1ea7n \u0111\u00e2y cho th\u1ea5y m\u1ed9t m\u00f4 h\u00ecnh r\u00f5 r\u00e0ng. B\u00e1o c\u00e1o qu\u00fd 2 ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025 \u0111\u00e3 t\u1ea1o ra s\u1ef1 bi\u1ebfn \u0111\u1ed9ng l\u1edbn, v\u1edbi c\u1ed5 phi\u1ebfu giao d\u1ecbch trong kho\u1ea3ng t\u1eeb $3.40 \u0111\u1ebfn $3.55 quanh th\u1eddi \u0111i\u1ec3m c\u00f4ng b\u1ed1. Bi\u1ebfn \u0111\u1ed9ng trong ng\u00e0y 4,4% l\u00e0 \u0111i\u1ec3n h\u00ecnh \u0111\u1ed1i v\u1edbi GDRX, v\u1ed1n c\u00f3 bi\u1ebfn \u0111\u1ed9ng h\u00e0ng tu\u1ea7n 13,9% so v\u1edbi m\u1ee9c trung b\u00ecnh 8,6% c\u1ee7a ng\u00e0nh ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe.<\/p>\n<p>B\u00e1o c\u00e1o qu\u00fd 1 tr\u01b0\u1edbc \u0111\u00f3 v\u00e0o th\u00e1ng 5 n\u0103m 2025 cho th\u1ea5y s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u00f2n \u1ea5n t\u01b0\u1ee3ng h\u01a1n\u2014c\u1ed5 phi\u1ebfu t\u0103ng t\u1eeb $3.73 v\u00e0o ng\u00e0y 15 th\u00e1ng 8 l\u00ean $5.06 v\u00e0o ng\u00e0y 18 th\u00e1ng 8, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng m\u1ee9c t\u0103ng 35,66% ch\u1ec9 trong ba ng\u00e0y sau tin t\u1ee9c h\u1ee3p t\u00e1c t\u00edch c\u1ef1c v\u1edbi Novo Nordisk.<\/p>\n<h3>Ph\u00e2n t\u00edch m\u00f4 h\u00ecnh ph\u1ea3n \u1ee9ng l\u1ee3i nhu\u1eadn<\/h3>\n<ul>\n<li><strong>Qu\u00fd 2 n\u0103m 2025 (7 th\u00e1ng 8)<\/strong>: Bi\u1ebfn \u0111\u1ed9ng trong ng\u00e0y 4,4% quanh b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/li>\n<li><strong>Qu\u00fd 1 n\u0103m 2025 (th\u00e1ng 5)<\/strong>: T\u0103ng 35,66% sau tin t\u1ee9c h\u1ee3p t\u00e1c<\/li>\n<li><strong>Qu\u00fd 4 n\u0103m 2024<\/strong>: Bi\u1ebfn \u0111\u1ed9ng \u0111i\u1ec3n h\u00ecnh 8-12% trong tu\u1ea7n b\u00e1o c\u00e1o<\/li>\n<li><strong>Qu\u00fd 3 n\u0103m 2024<\/strong>: Bi\u1ebfn \u0111\u1ed9ng 15% do k\u1ebft qu\u1ea3 h\u1ed7n h\u1ee3p<\/li>\n<li><strong>Qu\u00fd 2 n\u0103m 2024<\/strong>: Gi\u1ea3m 9% do lo ng\u1ea1i v\u1ec1 h\u01b0\u1edbng d\u1eabn<\/li>\n<li><strong>Qu\u00fd 1 n\u0103m 2024<\/strong>: T\u0103ng 22% nh\u1edd v\u01b0\u1ee3t k\u1ef3 v\u1ecdng t\u0103ng tr\u01b0\u1edfng \u0111\u0103ng k\u00fd<\/li>\n<\/ul>\n<p>M\u00f4 h\u00ecnh? GoodRx ph\u1ea3n \u1ee9ng m\u1ea1nh m\u1ebd v\u1edbi c\u1ea3 b\u1ea5t ng\u1edd l\u1ee3i nhu\u1eadn v\u00e0 th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c. C\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 th\u00f4ng minh theo d\u00f5i c\u00e1c ch\u1ea5t x\u00fac t\u00e1c n\u00e0y.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u00e0u L\u01b0\u1ee3n C\u1ea3m X\u00fac C\u00f3 M\u1ee5c \u0110\u00edch<\/h2>\n<p>Hi\u1ec7u su\u1ea5t g\u1ea7n \u0111\u00e2y c\u1ee7a GoodRx gi\u1ed1ng nh\u01b0 m\u1ed9t cu\u1ed1n ti\u1ec3u thuy\u1ebft ly k\u1ef3\u2014\u0111\u1ea7y nh\u1eefng kh\u00fac quanh nh\u01b0ng c\u00f3 c\u1ed1t truy\u1ec7n h\u1ea5p d\u1eabn. T\u1eeb th\u00e1ng 3 \u0111\u1ebfn th\u00e1ng 8 n\u0103m 2025, GDRX \u0111\u00e3 mang l\u1ea1i <strong>t\u0103ng 19,06%<\/strong> b\u1ea5t ch\u1ea5p nh\u1eefng th\u00e1ch th\u1ee9c c\u1ee7a ng\u00e0nh ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe.<\/p>\n<h3>Ph\u00e2n t\u00edch theo th\u00e1ng:<\/h3>\n<ul>\n<li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: $3.85 (b\u00e1n th\u00e1o ng\u00e0nh ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe tr\u00ean di\u1ec7n r\u1ed9ng)<\/li>\n<li><strong>Th\u00e1ng 4 n\u0103m 2025<\/strong>: $4.20 (+9% ph\u1ee5c h\u1ed3i)<\/li>\n<li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: $4.65 (+11% nh\u1edd v\u01b0\u1ee3t k\u1ef3 v\u1ecdng l\u1ee3i nhu\u1eadn qu\u00fd 1)<\/li>\n<li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: $4.10 (-12% lu\u00e2n chuy\u1ec3n ng\u00e0nh)<\/li>\n<li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: $4.75 (+16% \u0111\u1ed3n \u0111o\u00e1n h\u1ee3p t\u00e1c)<\/li>\n<li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: $4.56 (-4% h\u1ee3p nh\u1ea5t sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn)<\/li>\n<\/ul>\n<p>\u0110i\u1ec1u g\u00ec \u0111\u00e3 th\u00fac \u0111\u1ea9y bi\u1ebfn \u0111\u1ed9ng n\u00e0y? Ba y\u1ebfu t\u1ed1 ch\u00ednh: s\u1ef1 kh\u00f4ng ch\u1eafc ch\u1eafn c\u1ee7a th\u1ecb tr\u01b0\u1eddng thu\u1ed1c k\u00ea \u0111\u01a1n, tin t\u1ee9c m\u1edf r\u1ed9ng d\u1ecbch v\u1ee5 y t\u1ebf t\u1eeb xa, v\u00e0 h\u1ee3p t\u00e1c l\u1edbn v\u1edbi Novo Nordisk \u0111\u00e3 \u0111\u1ea9y c\u1ed5 phi\u1ebfu t\u0103ng 35% trong v\u00e0i ng\u00e0y.<\/p>\n<p>Ph\u1ea1m vi gi\u00e1 trong 52 tu\u1ea7n c\u1ee7a c\u1ed5 phi\u1ebfu k\u1ec3 c\u00e2u chuy\u1ec7n l\u1edbn h\u01a1n\u2014t\u1eeb m\u1ee9c th\u1ea5p $3.31 \u0111\u1ebfn cao $8.80. \u0110\u00f3 l\u00e0 <strong>ti\u1ec1m n\u0103ng t\u0103ng 166%<\/strong> t\u1eeb m\u1ee9c hi\u1ec7n t\u1ea1i n\u1ebfu GDRX c\u00f3 th\u1ec3 l\u1ea5y l\u1ea1i \u0111\u1ec9nh. Ngay c\u1ea3 m\u1ee9c gi\u00e1 trung b\u00ecnh 52 tu\u1ea7n $5.24 c\u0169ng cho th\u1ea5y ti\u1ec1m n\u0103ng t\u0103ng 15% t\u1eeb \u0111\u00e2y.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Qu\u1ef9 \u0110\u1ea1o T\u0103ng Tr\u01b0\u1edfng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o hi\u1ec7n t\u1ea1i c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u00e0 n\u1ec1n t\u1ea3ng c\u00f4ng ty, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 mang l\u1ea1i:<\/p>\n<ul>\n<li><strong>M\u1ee5c ti\u00eau cu\u1ed1i n\u0103m 2025<\/strong>: $7.86 (<strong>+72% so v\u1edbi hi\u1ec7n t\u1ea1i<\/strong>)<br \/>C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 \u0111o\u00e1n th\u00e1ng 12 c\u00f3 th\u1ec3 th\u1ea5y GDRX \u0111\u1ea1t $12.05 n\u1ebfu \u0111\u00e0 h\u1ee3p t\u00e1c ti\u1ebfp t\u1ee5c, m\u1eb7c d\u00f9 m\u1ee9c trung b\u00ecnh th\u1eadn tr\u1ecdng h\u01a1n l\u00e0 $7.86 c\u00f3 v\u1ebb th\u1ef1c t\u1ebf do c\u00e1c r\u00e0o c\u1ea3n ph\u00e1p l\u00fd.<\/li>\n<li><strong>Tri\u1ec3n v\u1ecdng 2026<\/strong>: $17.21 (<strong>+277% so v\u1edbi hi\u1ec7n t\u1ea1i<\/strong>)<br \/>M\u1ee5c ti\u00eau tham v\u1ecdng n\u00e0y gi\u1ea3 \u0111\u1ecbnh m\u1edf r\u1ed9ng d\u1ecbch v\u1ee5 y t\u1ebf t\u1eeb xa th\u00e0nh c\u00f4ng v\u00e0 gi\u00e0nh th\u1ecb ph\u1ea7n t\u1eeb c\u00e1c nh\u00e0 qu\u1ea3n l\u00fd l\u1ee3i \u00edch d\u01b0\u1ee3c ph\u1ea9m truy\u1ec1n th\u1ed1ng.<\/li>\n<li><strong>D\u1ef1 b\u00e1o 2028<\/strong>: Ph\u1ea1m vi $25-30<br \/>\u0110\u1ebfn n\u0103m 2028, d\u1ef1 ki\u1ebfn GoodRx s\u1ebd th\u1ed1ng l\u0129nh kh\u00f4ng gian \u0111\u01a1n thu\u1ed1c k\u1ef9 thu\u1eadt s\u1ed1 v\u1edbi ti\u1ec1m n\u0103ng m\u1edf r\u1ed9ng qu\u1ed1c t\u1ebf.<\/li>\n<li><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: Ti\u1ec1m n\u0103ng $40-50<br \/>N\u1ebfu s\u1ed1 h\u00f3a ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe t\u0103ng t\u1ed1c nh\u01b0 d\u1ef1 ki\u1ebfn, GDRX c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh m\u1ed9t c\u1ed5 phi\u1ebfu h\u1ea1 t\u1ea7ng y t\u1ebf t\u1eeb xa kh\u00f4ng th\u1ec3 thi\u1ebfu.<\/li>\n<\/ul>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n. T\u1ef7 l\u1ec7 r\u1ee7i ro-l\u1ee3i nhu\u1eadn \u1edf m\u1ee9c hi\u1ec7n t\u1ea1i \u1ee7ng h\u1ed9 t\u00edch l\u0169y, m\u1eb7c d\u00f9 trung b\u00ecnh gi\u00e1 theo t\u1eebng \u0111\u1ee3t qua b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn th\u00e1ng 11 l\u00e0 kh\u00f4n ngoan.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh so v\u1edbi T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i ro khi\u1ebfn nh\u00e0 giao d\u1ecbch tr\u0103n tr\u1edf:<\/h3>\n<ul>\n<li><strong>R\u1ee7i ro ph\u00e1p l\u00fd<\/strong>: Lu\u1eadt ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe thay \u0111\u1ed5i li\u00ean t\u1ee5c\u2014m\u1ed9t d\u1ef1 lu\u1eadt x\u1ea5u c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng m\u00f4 h\u00ecnh kinh doanh<\/li>\n<li><strong>B\u1ea5t \u1ed5n ng\u00e0nh d\u01b0\u1ee3c<\/strong>: V\u1ee5 ph\u00e1 s\u1ea3n c\u1ee7a Rite Aid cho th\u1ea5y s\u1ef1 mong manh c\u1ee7a ng\u00e0nh (<a href=\"https:\/\/www.ainvest.com\/news\/gdrx-high-risk-hold-sell-signal-2025-clash-momentum-fundamentals-2508\/\">AInvest<\/a>)<\/li>\n<li><strong>Bi\u1ebfn \u0111\u1ed9ng cao<\/strong>: Bi\u1ebfn \u0111\u1ed9ng h\u00e0ng tu\u1ea7n 14% g\u00e2y c\u1ea3m gi\u00e1c c\u0103ng th\u1eb3ng<\/li>\n<li><strong>Nh\u1ea1y c\u1ea3m kinh t\u1ebf<\/strong>: Suy tho\u00e1i l\u00e0m gi\u1ea3m chi ti\u00eau thu\u1ed1c k\u00ea \u0111\u01a1n ngay l\u1eadp t\u1ee9c<\/li>\n<\/ul>\n<h3>T\u00edn hi\u1ec7u t\u00edch c\u1ef1c cho n\u0103m 2025:<\/h3>\n<ul>\n<li><strong>Y\u00eau th\u00edch c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: 9 nh\u00e0 ph\u00e2n t\u00edch \u0111\u1eb7t m\u1ee5c ti\u00eau trung b\u00ecnh $6.33 (<strong>+39% ti\u1ec1m n\u0103ng t\u0103ng<\/strong>)<\/li>\n<li><strong>S\u1ee9c m\u1ea1nh h\u1ee3p t\u00e1c<\/strong>: Th\u1ecfa thu\u1eadn v\u1edbi Novo Nordisk cho th\u1ea5y s\u1ef1 c\u00f4ng nh\u1eadn t\u1eeb ng\u00e0nh d\u01b0\u1ee3c l\u1edbn<\/li>\n<li><strong>T\u0103ng tr\u01b0\u1edfng y t\u1ebf t\u1eeb xa<\/strong>: GoodRx Care m\u1edf r\u1ed9ng nhanh ch\u00f3ng<\/li>\n<li><strong>Xu h\u01b0\u1edbng ng\u00e0nh<\/strong>: \u00c1p d\u1ee5ng y t\u1ebf k\u1ef9 thu\u1eadt s\u1ed1 t\u0103ng t\u1ed1c sau \u0111\u1ea1i d\u1ecbch<\/li>\n<li><strong>S\u1ee9c kh\u1ecfe t\u00e0i ch\u00ednh<\/strong>: Doanh thu qu\u00fd 2 \u0111\u1ea1t $203 tri\u1ec7u v\u1edbi bi\u00ean l\u1ee3i nhu\u1eadn g\u1ed9p 93,68%<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Mua 10-20 c\u1ed5 phi\u1ebfu \u0111\u1ec3 th\u1eed nghi\u1ec7m\u2014bi\u1ebfn \u0111\u1ed9ng c\u1ee7a GDRX \u0111\u00f2i h\u1ecfi s\u1ef1 th\u1eadn tr\u1ecdng<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o l\u1ee3i nhu\u1eadn<\/strong>: \u0110\u00e1nh d\u1ea5u ng\u00e0y 6 th\u00e1ng 11 v\u00e0 l\u00ean k\u1ebf ho\u1ea1ch v\u00e0o l\u1ec7nh quanh k\u1ebft qu\u1ea3<\/li>\n<li><strong>S\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n<\/strong>: Kh\u00f4ng bao gi\u1edd d\u00f9ng l\u1ec7nh th\u1ecb tr\u01b0\u1eddng cho c\u1ed5 phi\u1ebfu n\u00e0y\u2014bi\u00ean \u0111\u1ed9 gi\u00e1 c\u00f3 th\u1ec3 r\u1ed9ng<\/li>\n<li><strong>\u0110a d\u1ea1ng h\u00f3a th\u00f4ng minh<\/strong>: Gi\u1eef GDRX d\u01b0\u1edbi 5% t\u1ed5ng danh m\u1ee5c \u0111\u1ea7u t\u01b0<\/li>\n<li><strong>Theo d\u00f5i tin t\u1ee9c ng\u00e0nh d\u01b0\u1ee3c<\/strong>: Th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c \u1ea3nh h\u01b0\u1edfng c\u1ed5 phi\u1ebfu nhi\u1ec1u h\u01a1n b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/li>\n<\/ol>\n<p>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc c\u1ee7a ng\u01b0\u1eddi c\u00f3 kinh nghi\u1ec7m: &#8220;Giao d\u1ecbch GDRX gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i n\u0103ng nh\u01b0ng kh\u00f3 \u0111o\u00e1n\u2014ti\u1ec1m n\u0103ng h\u1ed3i h\u1ed9p nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb thu\u1ed1c ki\u00ean nh\u1eabn!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu GoodRx Holdings, Inc. (GDRX) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn N\u1ec1n T\u1ea3ng<\/td>\n<td>\u0110\u1ea3m b\u1ea3o n\u1ec1n t\u1ea3ng c\u00f3 truy c\u1eadp NASDAQ v\u00e0 cho ph\u00e9p mua c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>N\u1ea1p Ti\u1ec1n V\u00e0o T\u00e0i Kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi $100-500 \u0111\u1ec3 l\u00e0m quen v\u1edbi nh\u1ecbp \u0111i\u1ec7u c\u1ed5 phi\u1ebfu<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Nghi\u00ean C\u1ee9u Gi\u00e1 Hi\u1ec7n T\u1ea1i<\/td>\n<td>Ki\u1ec3m tra bi\u1ebfn \u0111\u1ed9ng tr\u01b0\u1edbc gi\u1edd m\u1edf c\u1eeda v\u00e0 sau gi\u1edd giao d\u1ecbch<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>\u0110\u1eb7t L\u1ec7nh Gi\u1edbi H\u1ea1n<\/td>\n<td>\u0110\u1eb7t \u1edf m\u1ee9c $4.50 ho\u1eb7c th\u1ea5p h\u01a1n \u0111\u1ec3 tr\u00e1nh tr\u1ea3 gi\u00e1 cao<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>X\u00e1c Nh\u1eadn K\u00edch Th\u01b0\u1edbc V\u1ecb Th\u1ebf<\/td>\n<td>Gi\u1eef kho\u1ea3n \u0111\u1ea7u t\u01b0 ban \u0111\u1ea7u d\u01b0\u1edbi 3% t\u1ed5ng danh m\u1ee5c<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td>\n<td>$3.80 l\u00e0 h\u1ed7 tr\u1ee3 v\u00e0 $5.20 l\u00e0 kh\u00e1ng c\u1ef1 quan tr\u1ecdng<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u0110\u00e1nh Gi\u00e1 H\u00e0ng Qu\u00fd<\/td>\n<td>Theo d\u00f5i c\u00e1c ch\u1ec9 s\u1ed1 kh\u1ed1i l\u01b0\u1ee3ng \u0111\u01a1n thu\u1ed1c trong b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Theo D\u00f5i Tin T\u1ee9c Ng\u00e0nh<\/td>\n<td>Thay \u0111\u1ed5i ch\u00ednh s\u00e1ch ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe \u1ea3nh h\u01b0\u1edfng l\u1edbn \u0111\u1ebfn GDRX<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Xem X\u00e9t DRIP<\/td>\n<td>T\u1ef1 \u0111\u1ed9ng t\u00e1i \u0111\u1ea7u t\u01b0 c\u1ed5 t\u1ee9c n\u1ebfu c\u00f3<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u0110\u00e1nh Gi\u00e1 L\u1ea1i Chi\u1ebfn L\u01b0\u1ee3c H\u00e0ng Qu\u00fd<\/td>\n<td>\u0110i\u1ec1u ch\u1ec9nh d\u1ef1a tr\u00ean c\u00e1c th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 GoodRx<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi theo d\u00f5i bi\u1ebfn \u0111\u1ed9ng c\u1ee7a GDRX, Pocket Option mang l\u1ea1i nh\u1eefng l\u1ee3i th\u1ebf \u0111\u1ed9c \u0111\u00e1o:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u $5<\/strong>\u2014ho\u00e0n h\u1ea3o \u0111\u1ec3 th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi k\u00edch th\u01b0\u1edbc v\u1ecb th\u1ebf nh\u1ecf ph\u00f9 h\u1ee3p v\u1edbi h\u1ed3 s\u01a1 r\u1ee7i ro c\u1ee7a GDRX<\/li>\n<li><strong>X\u00e1c minh KYC trong 1 ph\u00fat<\/strong>\u2014t\u1ea3i l\u00ean b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd t\u00f9y th\u00e2n n\u00e0o v\u00e0 b\u1eaft \u0111\u1ea7u giao d\u1ecbch trong c\u00e1c giai \u0111o\u1ea1n b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn quan tr\u1ecdng<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong>\u2014truy c\u1eadp l\u1ee3i nhu\u1eadn ngay khi GDRX c\u00f3 nh\u1eefng bi\u1ebfn \u0111\u1ed9ng nhanh \u0111\u1eb7c tr\u01b0ng<\/li>\n<\/ul>\n<p>T\u1ed1c \u0111\u1ed9 th\u1ef1c thi nhanh c\u1ee7a n\u1ec1n t\u1ea3ng l\u00fd t\u01b0\u1edfng \u0111\u1ec3 n\u1eafm b\u1eaft c\u00e1c bi\u1ebfn \u0111\u1ed9ng 14% h\u00e0ng tu\u1ea7n c\u1ee7a GoodRx, trong khi m\u1ee9c n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p gi\u00fap b\u1ea1n luy\u1ec7n t\u1eadp qu\u1ea3n l\u00fd v\u1ecb th\u1ebf m\u00e0 kh\u00f4ng b\u1ecb ph\u01a1i b\u00e0y qu\u00e1 m\u1ee9c.<\/p>\n<h2>\ud83c\udf0d GoodRx N\u0103m 2025: C\u1ea7u N\u1ed1i K\u1ef9 Thu\u1eadt S\u1ed1 Trong Ch\u0103m S\u00f3c S\u1ee9c Kh\u1ecfe<\/h2>\n<p>GoodRx Holdings kh\u00f4ng ch\u1ec9 l\u00e0 m\u1ed9t c\u1ed5 phi\u1ebfu\u2014\u0111\u00f3 l\u00e0 m\u1ed9t cu\u1ed9c c\u00e1ch m\u1ea1ng trong ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe. C\u00f4ng ty k\u1ebft n\u1ed1i h\u01a1n 20 tri\u1ec7u ng\u01b0\u1eddi M\u1ef9 v\u1edbi thu\u1ed1c men gi\u00e1 c\u1ea3 ph\u1ea3i ch\u0103ng th\u00f4ng qua n\u1ec1n t\u1ea3ng so s\u00e1nh gi\u00e1, gi\u00fap ng\u01b0\u1eddi d\u00f9ng ti\u1ebft ki\u1ec7m kho\u1ea3ng 30 t\u1ef7 \u0111\u00f4 la k\u1ec3 t\u1eeb khi th\u00e0nh l\u1eadp.<\/p>\n<p>V\u1edbi 25% th\u1ecb ph\u1ea7n trong ti\u1ebft ki\u1ec7m thu\u1ed1c k\u00ea \u0111\u01a1n, GoodRx chi\u1ebfm \u01b0u th\u1ebf so v\u1edbi c\u00e1c \u0111\u1ed1i th\u1ee7 nh\u01b0 SingleCare (15%) v\u00e0 WellRx (10%). Vi\u1ec7c m\u1edf r\u1ed9ng sang d\u1ecbch v\u1ee5 y t\u1ebf t\u1eeb xa qua GoodRx Care gi\u00fap h\u1ecd c\u00f3 v\u1ecb th\u1ebf ho\u00e0n h\u1ea3o cho t\u01b0\u01a1ng lai k\u1ef9 thu\u1eadt s\u1ed1 c\u1ee7a ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe.<\/p>\n<p><strong>S\u1ef1 ki\u1ec7n th\u00fa v\u1ecb n\u0103m 2025<\/strong>: D\u1eef li\u1ec7u c\u1ee7a GoodRx cho th\u1ea5y trong \u0111\u1ee3t n\u1eafng n\u00f3ng th\u00e1ng 8 n\u0103m 2025, l\u01b0\u1ee3t t\u00ecm ki\u1ebfm thu\u1ed1c hen suy\u1ec5n t\u0103ng 300% \u1edf c\u00e1c bang Trung T\u00e2y\u2014n\u1ec1n t\u1ea3ng \u0111\u1ecbnh gi\u00e1 theo th\u1eddi gian th\u1ef1c c\u1ee7a h\u1ecd \u0111\u00e3 gi\u00fap b\u1ec7nh nh\u00e2n t\u00ecm \u0111\u01b0\u1ee3c \u1ed1ng h\u00edt kh\u1ea9n c\u1ea5p v\u1edbi m\u1ee9c gi\u1ea3m gi\u00e1 l\u00ean \u0111\u1ebfn 80% trong kh\u1ee7ng ho\u1ea3ng.<\/p>\n"},"faq":[{"question":"GoodRx Holdings, Inc. (GDRX) l\u00e0 c\u00f4ng ty g\u00ec?","answer":"GoodRx Holdings, Inc. l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe chuy\u00ean cung c\u1ea5p n\u1ec1n t\u1ea3ng so s\u00e1nh gi\u00e1 thu\u1ed1c k\u00ea \u0111\u01a1n gi\u00fap ng\u01b0\u1eddi d\u00f9ng ti\u1ebft ki\u1ec7m chi ph\u00ed thu\u1ed1c men."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu GDRX?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu GDRX th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 truy c\u1eadp NASDAQ v\u00e0 h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu l\u1ebb, theo c\u00e1c b\u01b0\u1edbc nh\u01b0 ch\u1ecdn n\u1ec1n t\u1ea3ng, n\u1ea1p ti\u1ec1n, \u0111\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i tin t\u1ee9c."},{"question":"C\u00f3 nh\u1eefng r\u1ee7i ro n\u00e0o khi \u0111\u1ea7u t\u01b0 v\u00e0o GDRX?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m thay \u0111\u1ed5i quy \u0111\u1ecbnh ph\u00e1p l\u00fd, s\u1ef1 b\u1ea5t \u1ed5n trong ng\u00e0nh d\u01b0\u1ee3c, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 nh\u1ea1y c\u1ea3m v\u1edbi t\u00ecnh h\u00ecnh kinh t\u1ebf."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu GDRX trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o gi\u00e1 GDRX c\u00f3 th\u1ec3 t\u0103ng l\u00ean $7.86 v\u00e0o cu\u1ed1i n\u0103m 2025, $17.21 v\u00e0o n\u0103m 2026, v\u00e0 c\u00f3 ti\u1ec1m n\u0103ng \u0111\u1ea1t $40-50 v\u00e0o n\u0103m 2030 n\u1ebfu c\u00e1c xu h\u01b0\u1edbng ph\u00e1t tri\u1ec3n k\u1ef9 thu\u1eadt s\u1ed1 ti\u1ebfp t\u1ee5c."},{"question":"Nh\u1eefng l\u1eddi khuy\u00ean n\u00e0o d\u00e0nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi khi mua c\u1ed5 phi\u1ebfu GDRX?","answer":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 l\u01b0\u1ee3ng nh\u1ecf, \u0111\u1eb7t c\u1ea3nh b\u00e1o l\u1ee3i nhu\u1eadn, s\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n, \u0111a d\u1ea1ng h\u00f3a danh m\u1ee5c v\u00e0 theo d\u00f5i k\u1ef9 c\u00e1c tin t\u1ee9c v\u1ec1 h\u1ee3p t\u00e1c v\u00e0 ng\u00e0nh d\u01b0\u1ee3c."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"GoodRx Holdings, Inc. (GDRX) l\u00e0 c\u00f4ng ty g\u00ec?","answer":"GoodRx Holdings, Inc. l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe chuy\u00ean cung c\u1ea5p n\u1ec1n t\u1ea3ng so s\u00e1nh gi\u00e1 thu\u1ed1c k\u00ea \u0111\u01a1n gi\u00fap ng\u01b0\u1eddi d\u00f9ng ti\u1ebft ki\u1ec7m chi ph\u00ed thu\u1ed1c men."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu GDRX?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu GDRX th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 truy c\u1eadp NASDAQ v\u00e0 h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu l\u1ebb, theo c\u00e1c b\u01b0\u1edbc nh\u01b0 ch\u1ecdn n\u1ec1n t\u1ea3ng, n\u1ea1p ti\u1ec1n, \u0111\u1eb7t l\u1ec7nh gi\u1edbi h\u1ea1n v\u00e0 theo d\u00f5i tin t\u1ee9c."},{"question":"C\u00f3 nh\u1eefng r\u1ee7i ro n\u00e0o khi \u0111\u1ea7u t\u01b0 v\u00e0o GDRX?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m thay \u0111\u1ed5i quy \u0111\u1ecbnh ph\u00e1p l\u00fd, s\u1ef1 b\u1ea5t \u1ed5n trong ng\u00e0nh d\u01b0\u1ee3c, bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao v\u00e0 nh\u1ea1y c\u1ea3m v\u1edbi t\u00ecnh h\u00ecnh kinh t\u1ebf."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu GDRX trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"C\u00e1c nh\u00e0 ph\u00e2n t\u00edch d\u1ef1 b\u00e1o gi\u00e1 GDRX c\u00f3 th\u1ec3 t\u0103ng l\u00ean $7.86 v\u00e0o cu\u1ed1i n\u0103m 2025, $17.21 v\u00e0o n\u0103m 2026, v\u00e0 c\u00f3 ti\u1ec1m n\u0103ng \u0111\u1ea1t $40-50 v\u00e0o n\u0103m 2030 n\u1ebfu c\u00e1c xu h\u01b0\u1edbng ph\u00e1t tri\u1ec3n k\u1ef9 thu\u1eadt s\u1ed1 ti\u1ebfp t\u1ee5c."},{"question":"Nh\u1eefng l\u1eddi khuy\u00ean n\u00e0o d\u00e0nh cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi khi mua c\u1ed5 phi\u1ebfu GDRX?","answer":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 l\u01b0\u1ee3ng nh\u1ecf, \u0111\u1eb7t c\u1ea3nh b\u00e1o l\u1ee3i nhu\u1eadn, s\u1eed d\u1ee5ng l\u1ec7nh gi\u1edbi h\u1ea1n, \u0111a d\u1ea1ng h\u00f3a danh m\u1ee5c v\u00e0 theo d\u00f5i k\u1ef9 c\u00e1c tin t\u1ee9c v\u1ec1 h\u1ee3p t\u00e1c v\u00e0 ng\u00e0nh d\u01b0\u1ee3c."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T14:49:44+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)\",\"datePublished\":\"2025-08-25T14:49:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"datePublished\":\"2025-08-25T14:49:44+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T14:49:44+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)","datePublished":"2025-08-25T14:49:44+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","datePublished":"2025-08-25T14:49:44+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-goodrx-holdings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GoodRx Holdings, Inc. (GDRX)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":348646,"slug":"how-to-buy-goodrx-holdings","post_title":"Como comprar a\u00e7\u00f5es da GoodRx Holdings, Inc. (GDRX) - Investimento em a\u00e7\u00f5es da GoodRx Holdings, Inc. (GDRX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-goodrx-holdings\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/348651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=348651"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/348651\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334126"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=348651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=348651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=348651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}